Hypercalciuria;Les hypercalciuries

Annales d'Endocrinologie

Volumn 66, Issue 6, 2005, Pages 532-539

  Perimenis P ^a   Wemeau J L ^a   Vantyghem, M C ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Hypercalcemia; Lithiasis; Tubulopathy

Indexed keywords

CALCIUM SENSING RECEPTOR; CARBOHYDRATE; CARBON; PHOSPHONIC ACID DERIVATIVE; SODIUM; VITAMIN D;

ACIDOSIS; BARTTER SYNDROME; BONE METASTASIS; CALCIUM ABSORPTION; CALCIUM TRANSPORT; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DIET; FANCONI ANEMIA; HUMAN; HYPERCALCIURIA; HYPERTHYROIDISM; HYPOCALCEMIA; HYPOMAGNESEMIA; KIDNEY DISTAL TUBULE; KIDNEY TUBULE ACIDOSIS; LYMPHOMA; MYELOMA; NUTRITION; OSTEOLYSIS; PAGET BONE DISEASE; PSEUDOHYPOALDOSTERONISM; REVIEW; SARCOIDOSIS; SODIUM INTAKE;

EID: 29144469441     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(05)82114-6     Document Type: Short Survey

References (60)

1. Audran M, Legrand E. Hypercalciuria. Joint Bone Spine 2000 ; 67 : 509-15.
2. Barley NF, Howard A, O'Callaghan D, Legon S, Walters JR. Epithelial calcium transporter expression in human duodenum Am J Physiol Gastrointest Liver Physiol 2001 ; 280 : G285-90.
3. Bartter FC, Pronove P, Gill JR Jr, Maccardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 1962 ; 33 : 811-28.
4. Bereket A, Erdogan T. Oral bisphosphonate therapy for vitamin D intoxication of the infant. Pediatrics 2003 ; 111 : 899-901.
5. Berio A. Primary Toni-Debre-Fanconi syndrome. Pediatr Med Chir 1993 ; 15 : 79-85.
6. Birkenhager R, Otto E, Schurmann MJ et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 2001 ; 29 : 310-4.
7. Blanchard A, Jeunemaitre X, Coruol P et al. Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 2001 ; 59 : 2206-15.
8. Bronner F, Pansu D. Nutritional aspects of calcium absorption. J Nutr 1999 ; 129 : 9-12.
9. Brown EM. Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med 1999 ; 106 : 238-53.
10. Buckalew VM Jr. Nephrolithiasis in renal tubular acidosis. J Urol 1989 ; 141 : 731-7.
11. Bushinsky DA. Nephrolithiasis. J Am Soc Nephrol 1998 ; 9 : 917-24.
12. Canalis E. Clinical review 83 : Mechanisms of glucocorticoid action in bone : implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996 ; 81 : 3441-7.
13. Carpenter TO, Carnes DL Jr, Anast CS. Hypoparathyroidism in Wilson's disease. N Engl J Med 1983 ; 309 : 873-7.
14. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992 ; 327 : 1141-52.
15. Dent CE, Friedman M. Hypercalciuric rickets associated with renal tubular damage. Arch Dis Child 1964 ; 39 : 240-9.
16. Domrongkitchaiporn S, Pongsakul C, Stitchantrakul W et al. Bone mineral density and histology in distal renal tubular acidosis. Kidney Int 2001 ; 59 : 1086-93.
17. Faggiano A, Pivonello R, Melis D et al. Nephrolithiasis in Cushing's disease : prevalence, etiopathogenesis, and modification after disease cure. J Clin Endocrinol Metab 2003 ; 88 : 2076-80.
18. Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcemic and metastatic bone disease. Drugs 1991 Dec ; 42 : 919-44.
19. Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 2003 ; 14 : 1082-95.
20. Gavras I. Prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002 ; 346 : 1667-9.
21. Hebert SC, Gamba G. Molecular cloning and characterization of the renal diuretic-sensitive electroneutral sodium- (potassium)-chloride cotransporters. Clin Investig 1994 ; 72 : 692-4.
22. Hebert SC. Bartter syndrome. Curr Opin Nephrol Hypertens 2003 ; 12 : 527-32.
23. Heilberg IP, Martini LA, Teixeira SH et al. Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia. Nephron 1998 Aug ; 79 : 430-7.
24. Hoenderop JG, Nilius B, Bindels RJ. Molecular mechanism of active Ca2 + reabsorption in the distal nephron. Annu Rev Physiol 2002 ; 64 : 529-49.
25. Hoenderop JG, van der Kemp AW, Hartog A et al. Molecular identification of the apical Ca2 + channel in 1, 25-dihydroxy-vitamin D3-responsive epithelia. J Biol Chem 1999 ; 274 : 8375-8.
26. Imamura K, Tonoki H, Wakui K et al. 4q33-qter deletion and absorptive hypercalciuria : report of two unrelated girls. Am J Med Genet 1998 ; 78 : 52-4.
27. Ito H, Kotake T, Suzuki F. Incidence and clinical features of renal tubular acidosis-1 in urolithiasis. Urol Int 1993 ; 50 : 82-5.
28. Jaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C. Low bone mass in idiopathic renal stone formers : magnitude and significance. J Bone Miner Res 1994 ; 9 : 1525-32.
29. Kari JA, Farouq M, Alshaya HO. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatr Nephrol 2003 ; 18 : 506-10.
30. Knox JB, Demling RH, Wilmore DW, Sarraf P, Santos AA. Hypercalcemia associated with the use of human growth hormone in an adult surgical intensive care unit. Arch Surg 1995 ; 130 : 442-5.
31. Konrad M, Vollmer M, Lemmink HH et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 2000 ; 11 : 1449-59.
32. Legroux-Gerot I, Catanzariti L, Marchandise X, Duquesnoy B, Cortet B. Bone mineral density changes in hypercalciuretic osteoporotic men treated with thiazide diuretics. Joint Bone Spine 2004 ; 71 : 51-5.
33. Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis : an update of a 1980 protocol. Am J Med 1995 ; 98 : 50-9.
34. Lienhardt A, Bai M, Lagarde JP, Rigaud M et al. Activating mutations of the calcium-sensing receptor : management of hypocalcemia. J Clin Endocrinol Metab 2001 ; 86 : 5313-23.
35. Luyckx VA, Goda FO, Mount DB et al. Intrarenal and subcellular localization of rat CLC5. Am J Physiol 1998 ; 275 : F761-9.
36. Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z Pseudohypoaldosteronism type II : marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 2002 ; 87 : 3248-54.
37. Montaigne D, Perimenis P, Douillard C, Wémeau JL, Vantyghem MC. Hypomagnésémies congénitales. Presse Med 2004 : 1341-8.
38. Pack CY, Heller HJ, Perale MS, Odvina CV, Poindexter JR, Peterson RD. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol 2003 ; 169 : 465-469.
39. Parks JH, Coe FL, Strauss AL. Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med 1982 ; 306 : 1088-91.
40. Pearce SH. Clinical disorders of extracellular calcium-sensing and the molecular biology of the calcium-sensing receptor. Ann Med 2002 ; 34 : 201-6.
41. Peng JB, Chen XZ, Berger LJV, Vassilev PM et al. Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 1999 ; 274 : 22739-46.
42. Reed BY, Heller HJ, Gitomer WL, Pak CY. Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab 1999 ; 84 : 3907-13.
43. Rico H, Revilla M, Villa LF, Arribas I, de Buergo MA. A longitudinal study of total and regional bone mineral content and biochemical markers of bone resorption in patients with idiopathic hypercalciuria on thiazide treatment. Miner Electrolyte Metab 1993 ; 19 : 337-42.
44. Rodriguez-Soriano J. Why does renal tubular acidosis cause hypercalciuria ? Pediatr Nephrol 1992 ; 6 : 144.
45. Scott P, Ouimet D, Valiquette L et al. Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J Am Soc Nephrol 1999 ; 10 : 1007-13.
46. Sebastian A. Thiazides and bone. Am J Med 2000 ; 109 : 429-30.
47. Seymour JF, Gagel RF, Hagemeister FB, Dimopoulos MA, Cabanillas F. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med 1994 ; 121 : 633-40.
48. Simon DB, Karet FE, Rodriguez-Soriano J et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K channel, ROMK. Nat Genet 1996 ; 14 : 152-6.
49. Simon DB, Lu Y, Choate KA et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2 + resorption. Science 1999 ; 285 : 103-6.
50. Slepchenko BM, Bronner F. Modeling of transcellular Ca transport in rat duodenum points to coexistence of two mechanisms of apical entry. Am J Physiol Cell Physiol 2001 ; 281 : C270-81.
51. Thakker RV. Pathogenesis of Dent's disease and related syndromes of X-linked nephrolithiasis. Kidney Int 2000 ; 57 : 787-93.
52. Van Abel M, Hoenderop JG, van der Kemp AW, van Leeuwen JP, Bindels RJ. Regulation of the epithelial Ca2 + channels in small intestine as studied by quantitative mRNA detection. Am J Physiol Gastrointest Liver Physiol 2003 ; 285 : 78-85.
53. Vaidyanathan S, Watson ID, Jonsson O et al. Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury : is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosphate bladder stones ? Spinal Cord. 2005 Jan 18.
54. Vantyghem MC, Perimenis P, Wémeau JL. Pseudo-hypoaldosteronismes. Presse Med. 2004 ; 33 : 123-9.
55. Vezzoli G, Tanini A, Ferrucci L et al. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 2002 ; 13 : 2517-23.
56. Wang SS, Devuyst O, Courtoy PJ et al. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet 2000 ; 9 : 2937-45.
57. Wasnich RD, Benfante RJ, Yano K, Heilbrun L, Vogel JM. Thiazide effect on the mineral content of bone. N Engl J Med 1983 ; 309 : 344-7.
58. Weber S, Schlingmann KP, Peters M et al. Primary gene structure and expression studies of rodent paracellin-1. J Am Soc Nephrol 2001 ; 12 : 2664-72.
59. Wolf MT, Dotsch J, Konrad M, Boswald M, Rascher W. Followup of five patients with FHHNC due to mutations in the Paracellin-1 gene. Pediatr Nephrol 2002 ; 17 : 602-8.
60. Yagisawa T, Kobayashi C, Hayashi T, Yoshida A, Toma H. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney. Am J Kidney Dis 2001 ; 37 : 1140-3.